Cuatrecasas guides Partners Group in FairJourney Biologics deal
Cuatrecasas advised Partners Group on the acquisition, on behalf of its clients, of a majority stake in FairJourney Biologics from GHO Capital Partners. Partners Group is an international private equity firm, and FairJourney Biologics is a Portuguese biotechnology company specializing in the healthcare sector.
Founded in 2012 and headquartered in Porto, FairJourney is a contract research organization that supports pharmaceutical and biotechnology companies in developing the next generation of antibody-based therapies. Specifically, it provides services for the discovery, engineering, production, and characterization of antibodies, with established partnerships resulting in 14 therapies currently in active clinical development to address patient needs in oncology, immunology, and cardiovascular diseases.
The multidisciplinary of advisors
The multidisciplinary team at Cuatrecasas involved in the advisory was coordinated by M&A and Private Equity lawyers Mariana Norton dos Reis (pictured left) and Francisco Martins Caetano (pictured right), and included Pharmaceutical and Health Sciences lawyers Joana Silveira Botelho and Luís Ribeiro Telles, and Finance lawyer Manuel Requicha Ferreira. Lawyers from other areas, focusing on Intellectual Property, Public Law, and Labor Law, also participated. Cuatrecasas collaborated with Ropes & Gray on this transaction.
